Your AI-Trained Oncology Knowledge Connection!

Video

Dr. Arend on the PORTEC-3 Trial for Endometrial Cancer

Author(s):

Rebecca C. Arend, MD

In Partnership With:

Rebecca C. Arend, MD, assistant professor, UAB School of Medicine, UAB Department of Obstetrics and Gynecology, UAB Comprehensive Cancer Center, discusses the PORTEC-3 trial for patients with endometrial cancer.

Rebecca C. Arend, MD, assistant professor, UAB School of Medicine, UAB Department of Obstetrics and Gynecology, UAB Comprehensive Cancer Center, discusses the PORTEC-3 trial for patients with endometrial cancer.

This trial included patients with high/intermediate risk who received either radiation or radiation plus chemotherapy. According to Arend, if a patient has stage 3 endometrial cancer they should receive chemotherapy.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!
Related Videos
Syed Abbas Ali, MBBS, an assistant professor of oncology at Johns Hopkins School of Medicine and Sidney Kimmel Comprehensive Cancer Center
Oleg Gluz, MD, chief physician, Breast Cancer Niederrhein
R. Lor Randall, MD, FACS
Dr Zonder on the Need for Increased Awareness in Multiple Myeloma
Shilpa Gupta, MD, director of Genitourinary Medical Oncology at the Taussig Cancer Institute and co-leader of the Genitourinary Oncology Program in the Department of Hematology and Medical Oncology, Cleveland Clinic; as well as a member of the Developmental Therapeutics Program at the Case Comprehensive Cancer Center
Hyun-Woong Cho, MD, PhD, Department of Obstetrics and Gynecology, Korea University College of Medicine
SHAH
Timothy S. Fenske, MD, MS
Sheela Rao, MBBS, MD, FRCP
Related Content
The top 5 OncLive videos of the week cover insights in gynecologic cancer, multiple myeloma, urothelial cancer, MPNs, and prostate cancer.
March 23rd 2025

Five Under 5: Top Oncology Videos for the Week of 3/16

Bradley J. Monk, MD, FACOG, FACS; Paolo Tarantino, MD
January 11th 2024

Monk and Tarantino Describe the Investigation of B7-H4 Vedotin–Directed ADCs in Gynecologic and Breast Cancers

Gynecologic Oncology | Image Credit: © Crystal light - stock.adobe.com
March 21st 2025

Emerging ADCs, Biomarker-Driven Treatments, and Diagnostic Advancements Take Center Stage at the SGO Annual Meeting

R. Wendel Naumann, MD
October 26th 2023

Naumann Discusses Notable Research Efforts in Endometrial Cancer

Selinexor in Endometrial Cancer
March 17th 2025

Maintenance Selinexor Extends PFS in TP53 Wild-Type Endometrial Cancer

Image Credit: © Katsyarina – stock.adobe.com
March 17th 2025

Dostarlimab/Chemo Improves Long-Term DOR in Advanced Endometrial Cancer